NCT02830165View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 15, 2016

Primary Completion Date

May 9, 2020

Study Completion Date

May 27, 2022

Conditions
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT02830165 - Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter